Lidoflazine

Last updated
Lidoflazine
Lidoflazine.png
Clinical data
AHFS/Drugs.com International Drug Names
ATC code
Identifiers
  • 2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]-N-(2,6-dimethylphenyl)acetamide
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard 100.020.285 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C30H35F2N3O
Molar mass 491.627 g·mol−1
3D model (JSmol)
Melting point 159 to 161 °C (318 to 322 °F)
Solubility in water Almost insoluble in water(<0.01%); Very soluble in chloroform(>50%); mg/mL (20 °C)
  • CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F
  • InChI=1S/C30H35F2N3O/c1-22-5-3-6-23(2)30(22)33-29(36)21-35-19-17-34(18-20-35)16-4-7-28(24-8-12-26(31)13-9-24)25-10-14-27(32)15-11-25/h3,5-6,8-15,28H,4,7,16-21H2,1-2H3,(H,33,36) X mark.svgN
  • Key:ZBIAKUMOEKILTF-UHFFFAOYSA-N X mark.svgN
 X mark.svgNYes check.svgY  (what is this?)    (verify)

Lidoflazine is a piperazine calcium channel blocker. It is a coronary vasodilator with some antiarrhythmic action. [1] Lidoflazine was discovered at Janssen Pharmaceutica in 1964.

Contents

Physical properties

Solubility at room temperature

Extracted from [1]

Solvent0.01

N

0.1

N

 %pH %pH
Hydrochloric Acid0.43.00.71.9
Tartaric Acid0.33.11.02.5
Citric Acid0.33.10.52.5
Lactic Acid0.23.40.72.9
Acetic Acid0.13.50.43.8

References

  1. 1 2 Schaper WK, Xhoneux R, Jageneau AH, Janssen PA (May 1966). "The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator" . The Journal of Pharmacology and Experimental Therapeutics. 152 (2): 265–274. doi:10.1016/S0022-3565(25)27319-0. PMID   5944369.

Further reading

[1]


  1. Zhou PZ, Babcock J, Liu LQ, Li M, Gao ZB (June 2011). "Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules". Acta Pharmacologica Sinica. 32 (6): 781–788. doi:10.1038/aps.2011.70. PMC   4085723 . PMID   21623390.